Literature DB >> 23140297

Bioavailability challenges associated with development of saponins as therapeutic and chemopreventive agents.

Song Gao1, Sumit Basu, Zhen Yang, Arijita Deb, Ming Hu.   

Abstract

Saponins, a major class of natural phytochemicals, hold great promises for being developed into chemopreventive and chemotherapeutic drugs. However, one of the major factors limiting their pharmacological effects in vivo is poor bioavailability. This paper reviews the factors that determine the absorption and bioavailability of saponins including their physicochemical properties, and their absorption and disposition in the gastrointestinal tract. A critical review of the current research papers suggests that poor permeability and microflora hydrolysis of saponins are the primary factors that limit their bioavailabilities. Future investigations should be directed towards further optimization of the bioavailability of saponins to enhance their chemopreventive and chemotherapeutic effects in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23140297     DOI: 10.2174/138945012804545498

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  15 in total

1.  Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting the generation of hepatocyte growth factor via PPAR-γ in colon.

Authors:  Ying Xia; Yu-Feng Xia; Qi Lv; Meng-Fan Yue; Si-Miao Qiao; Yan Yang; Zhi-Feng Wei; Yue Dai
Journal:  Br J Pharmacol       Date:  2016-02-25       Impact factor: 8.739

Review 2.  Bioavailability Based on the Gut Microbiota: a New Perspective.

Authors:  Feng Zhang; Fang He; Li Li; Lichun Guo; Bin Zhang; Shuhuai Yu; Wei Zhao
Journal:  Microbiol Mol Biol Rev       Date:  2020-04-29       Impact factor: 11.056

Review 3.  Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence.

Authors:  Muthu K Shanmugam; Xiaoyun Dai; Alan Prem Kumar; Benny K H Tan; Gautam Sethi; Anupam Bishayee
Journal:  Cancer Lett       Date:  2014-01-30       Impact factor: 8.679

4.  Developing an activity and absorption-based quality control platform for Chinese traditional medicine: Application to Zeng-Sheng-Ping(Antitumor B).

Authors:  Taijun Yin; Guanyi Yang; Yong Ma; Beibei Xu; Ming Hu; Ming You; Song Gao
Journal:  J Ethnopharmacol       Date:  2015-06-20       Impact factor: 4.360

5.  The saponin D39 blocks dissociation of non-muscular myosin heavy chain IIA from TNF receptor 2, suppressing tissue factor expression and venous thrombosis.

Authors:  Ke-Feng Zhai; Jin-Rong Zheng; You-Mei Tang; Fang Li; Yan-Ni Lv; Yuan-Yuan Zhang; Zhen Gao; Jin Qi; Bo-Yang Yu; Jun-Ping Kou
Journal:  Br J Pharmacol       Date:  2017-07-18       Impact factor: 8.739

Review 6.  Immunomodulatory potential of dietary soybean-derived isoflavones and saponins in pigs.

Authors:  Brooke Nicole Smith; Ryan Neil Dilger
Journal:  J Anim Sci       Date:  2018-04-14       Impact factor: 3.159

Review 7.  Saponins from Chinese Medicines as Anticancer Agents.

Authors:  Xiao-Huang Xu; Ting Li; Chi Man Vivienne Fong; Xiuping Chen; Xiao-Jia Chen; Yi-Tao Wang; Ming-Qing Huang; Jin-Jian Lu
Journal:  Molecules       Date:  2016-10-05       Impact factor: 4.411

8.  Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D-phospholipid complex.

Authors:  Jinyang Shen; Jianping Bi; Hongli Tian; Ye Jin; Yuan Wang; Xiaolin Yang; Zhonglin Yang; Junping Kou; Fei Li
Journal:  Int J Nanomedicine       Date:  2016-09-26

Review 9.  Spice-Derived Bioactive Ingredients: Potential Agents or Food Adjuvant in the Management of Diabetes Mellitus.

Authors:  Aminu Mohammed; Md Shahidul Islam
Journal:  Front Pharmacol       Date:  2018-08-22       Impact factor: 5.810

10.  Intravenous and subcutaneous toxicity and absorption kinetics in mice and dogs of the antileishmanial triterpene saponin PX-6518.

Authors:  Louis Maes
Journal:  Molecules       Date:  2013-04-22       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.